Literature DB >> 10679391

Action of Myc in vivo - proliferation and apoptosis.

S Pelengaris1, B Rudolph, T Littlewood.   

Abstract

The protein products of many dominant oncogenes are capable of inducing both cell proliferation and apoptosis. Recent experiments employing transgenic mice that express an ectopically regulatable myc gene or protein have begun to elucidate the role of the balance between proliferation and apoptosis in Myc-induced carcinogenesis. An outstanding feature of these experiments is the demonstration that the balance between oncogene-induced proliferation and apoptosis in a given tissue can be a critical determinant in the initiation and maintenance of the tumor.

Entities:  

Mesh:

Year:  2000        PMID: 10679391     DOI: 10.1016/s0959-437x(99)00046-5

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  55 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.

Authors:  Adam Siddiqui-Jain; Cory L Grand; David J Bearss; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

Review 4.  Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions.

Authors:  Yong Qin; Laurence H Hurley
Journal:  Biochimie       Date:  2008-02-29       Impact factor: 4.079

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  An animal model of MYC-driven medulloblastoma.

Authors:  Yanxin Pei; Colin E Moore; Jun Wang; Alok K Tewari; Alexey Eroshkin; Yoon-Jae Cho; Hendrik Witt; Andrey Korshunov; Tracy-Ann Read; Julia L Sun; Earlene M Schmitt; C Ryan Miller; Anne F Buckley; Roger E McLendon; Thomas F Westbrook; Paul A Northcott; Michael D Taylor; Stefan M Pfister; Phillip G Febbo; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

7.  WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer.

Authors:  Hirohide Yoshikawa; Kenichi Matsubara; Xiaoling Zhou; Shu Okamura; Takahiko Kubo; Yaeko Murase; Yuko Shikauchi; Manel Esteller; James G Herman; Xin Wei Wang; Curtis C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

8.  Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter.

Authors:  Anh Tuân Phan; Yasha S Modi; Dinshaw J Patel
Journal:  J Am Chem Soc       Date:  2004-07-21       Impact factor: 15.419

9.  Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation.

Authors:  Anna Radziszewska; Stephanie A Schroer; Diana Choi; Panteha Tajmir; Nikolina Radulovich; James C Ho; Linyuan Wang; Nicole Liadis; Razqallah Hakem; Ming-Sound Tsao; Linda Z Penn; Gerard I Evan; Minna Woo
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

10.  Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.

Authors:  Li-Ling Lin; Chao-Cheng Huang; Chia-Ling Wu; Min-Tsui Wu; Wen-Ming Hsu; Jiin-Haur Chuang
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.